Does Extended-Release Naltrexone Worsen Psychiatric Symptoms?
The Carlat Addiction Treatment Report, Volume 7, Number 3&4, May 2019
https://www.thecarlatreport.com/newsletter-issue/catrv7n34/
Issue Links: Learning Objectives | Editorial Information
Topics: Naltrexone | Opioids | Research Update
Brian Frankel, MD.
Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Extended-release (XR) naltrexone (Vivitrol) is an injectable version of naltrexone that lasts for 4 weeks and is FDA approved for opioid use disorder (OUD). Although effective, there is some concern that XR naltrexone may cause or worsen psychiatric symptoms because of its opioid blockade.
You can't view details of this content, please login or buy subscription here